The immediate results of surgical treatment of coronary heart disease complicated with left ventricular aneurysm and mitral insufficiency
Abstract
Coronary heart disease is a fairly common cause of mitral regurgitation. In atherosclerosis of the coronary arteries changes of the mitral valve and mitral regurgitation of varying severity occur in 30% of patients.
Subjects were 32 consistently performed at the National Institute of Cardiovascular Surgery them. Amosov NAMS of Ukraine Associated coronary bypass surgery, surgery on left ventricular aneurysm and mitral valve during the period from 1 January 2012 to 31 December 2015. It should be noted that the majority of patients (75%), the operation was performed on the heart is stopped using cardioplegia. Correction concomitant mitral insufficiency was performed using plastic techniques (with preservation of subvalvular structures) and mitral valve replacement.
References
2. Comparison of three-dimensional echocardiographic findings to those of magnetic resonance imaging for determination of left ventricular mass in patients with ischemic and non-ischemic cardiomyopathy / Kusunose K., Kwon D. H., Motoki H. et al. // Am J Cardiol. – 2013. – Vol. 112. – 604–611.
3. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation / Goldstein D., Moskowitz A. J., Gelijns A. C. et al. // N Engl J Med. – 2016. – Vol. 374. – 344–353.
4. Functional capacity late after partial left ventriculectomy: relation to ventricular geometry and performance / Popovic Z., Miric M., Neskovic A. N. et al. // Eur J Cardio-thorac Surg. – 2001. – Vol. 19. – P. 61–67.
5. ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology /American Heart Association Task Force on Practice Guidelines / Nishimura R. A., Otto C. M., Bonow R. O. et al. // Circulation. – 2014. – Vol. 129. – P. 2440–2492.
6. The Euro Heart Failure survey programme a survey on the quality of care among patients with heart failure in Europe / Clenand J., Swedberg K., Follath F. // Eur Heart J. – 2007. – Vol. 24 (5). – P. 442–463.
7. Menicanti L. Surgical left ventricle reconstruction, pathophysiologic insight, results and expectation from the STICH trial / Menicanti L., M. Di Donato // Eur J Cardio-thorac Surg. – 2004. – Vol. 26. – P. 42–47.
8. Survival in patients with severe ischemic cardiomyopathy undergoing revascularization versus medical therapy: association with end-systolic volume and viability / Kwon D. H., Hachamovitch R., Popovic Z. B. et al. // Circulation. – 2012. – Vol. 126. – P. S3–S8.
9. Valsartan in Acute Myocardial Infarction (VALIANT) Investigators. Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarction / Meris A., Amigoni M., Verma A. et al. // J Am Soc Echocardiogr. – 2012. – Vol. 25. – P. 535–542.
10. Солєйко О. В. Клінічна еволюція хронічної постін-фарктної аневризми серця / О. В. Солєйко // Мисте-цтво лікування. – 2008. – № 5. – С. 60–64.
11. Risk factors for mortality and hospital re-admission after surgical ventricular restoration / Sartipy U., Albеge A., Lindblom D. // Eur. J. Cardiothor. Surgery. – 2006. – Vol. 30. – P. 762–769.
12. Edmunds L. H. Cardiac Surgery in the adult / Edmunds L. H., Glower D. D., Lowe J. E. – New York, 2003. – 1542 p.